Literature DB >> 16564181

Cell biology, MRI and geometry: insight into a microscopic/macroscopic marriage.

Sérgio Almeida de Oliveira1, Luís Henrique W Gowdak, Gerald Buckberg, José Eduardo Krieger.   

Abstract

OBJECTIVE: The concept of cell therapy as an adjunctive therapy to myocardial surgical revascularization for patients with severe coronary artery disease is illustrated by two case reports of ischemic cardiac disease that were unsuitable for revascularization by coronary grafting. The potential interaction of cell therapy, magnetic resonance imaging (MRI) of viability, and left ventricle (LV) restoration is described.
METHODS: Each patient had an ejection fraction below 30%, a relatively conical heart, and MRI gadolinium scan showing predominantly viable muscle.
RESULTS: Intramyocardial injections of autologous bone marrow-derived cells (BMC) were performed along with either incomplete coronary artery bypass grafting (CABG) (to mother regions) or with transmyocardial laser revascularization (TMLR). An improvement in contractile function was seen at 6-12-month intervals after the procedure.
CONCLUSIONS: The implications of possible underlying mechanisms of improvement in both myocardial perfusion and contractility suggest the striking importance of both micro- and macroenvironment for any cell-based therapeutic strategy. These observations imply that the interaction of cell biology, viability by MRI and geometry may be important in the future, as geometry can be restored surgically, and the new architectural form may develop enhanced function if it contains viable tissue and cell-based treatment can be delivered.

Entities:  

Mesh:

Year:  2006        PMID: 16564181     DOI: 10.1016/j.ejcts.2006.02.005

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

2.  Early increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.

Authors:  Luís Henrique Wolff Gowdak; Isolmar Tadeu Schettert; Carlos Eduardo Rochitte; Luiz Augusto Ferreira Lisboa; Luís Alberto Oliveira Dallan; Luiz Antônio Machado César; Sérgio Almeida de Oliveira; José Eduardo Krieger
Journal:  J Cardiovasc Transl Res       Date:  2011-02       Impact factor: 4.132

3.  Surgical Ventricular Restoration: An Operation to Reverse Remodeling - Clinical Application (Part II).

Authors:  Ganesh Shanmugam; Imtiaz S Ali
Journal:  Curr Cardiol Rev       Date:  2009-11

4.  Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study.

Authors:  Bernardo R Tura; Helena F Martino; Luis H Gowdak; Ricardo Ribeiro dos Santos; Hans F Dohmann; José E Krieger; Gilson Feitosa; Fábio Vilas-Boas; Sérgio A Oliveira; Suzana A Silva; Augusto Z Bozza; Radovan Borojevic; Antonio C Campos de Carvalho
Journal:  Trials       Date:  2007-01-18       Impact factor: 2.279

5.  Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold.

Authors:  Juliana S Nakamuta; Maria E Danoviz; Fabio L N Marques; Leonardo dos Santos; Claudia Becker; Giovana A Gonçalves; Paula F Vassallo; Isolmar T Schettert; Paulo J F Tucci; Jose E Krieger
Journal:  PLoS One       Date:  2009-06-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.